Bonafide Acquires SAM-e Nutritional Technology to Expand Pipeline of Women's Products.

MANews-(C)2009-2022

New York-based women's healthcare company Bonafide has acquired enhanced formulation of S-adenosylmethionine (SAM-e), to further deepen Bonafide's pipeline of products in the women's health space, the company said.

Terms of the transaction were not disclosed.

This acquisition boosts Bonafide's patent holdings to more than 50 issued and pending patents that it owns or exclusively licenses.

As part of this acquisition, Bonafide owns all assets...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT